5Knodell RR,Ishak KG,Black WC,et al. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology, 1981,1 ( 5 ) :431-436.
6Yuen MF,Nq IO,Fan ST,et al. Significance of HBV DNA levels in liver histology of HBeAg and anti-HBe positive patients with chronic hepatitis B. Am J Gastroenterol,2004,99: 2032-2037.
7Peng D,Han Y,Ding H,et al. Hepatic steatosis in chronic hepatitis B patients is associated with metabolic factors more than viral factors.J Gastroenterol Hepatol,2008,23 (7 Pt 1 ): 1082-1088.
8Alizadeh AH,Fallahian F,Alavian SM,et al.Insulin resistance in chronic hepatitis B and C.Indian J Gastroenterel,2006,25: 286-289.
9Oh MK,Winn J,Poordad F. Review article:diagnosis and treatment of non -alcoholic fatty liver disease. Aliment Pharmacol Ther, 2008,28 (5) : 503-522.
10Duseja A,Das A,Dhiman RK,et al. Meffbrmin is effective in achieving biochemical response in patients with nonalcoholic fatty liver disease (NAFLD)not responding to lifestyle interventions. Ann Hepatol, 2007,6 : 222-226.
